Based on the most recent 2015 NMOSD diagnostic criteria, the diagnosis of AQP4-IgG NMOSD requires the presence of (i) 1 clinical core feature including optic neuritis, acute transverse myelitis, APS, acute brainstem syndrome, narcolepsy or acute diencephalic lesion or symptomatic cerebral syndrome with typical NMOSD brain lesions, (ii) positive testing for AQP4-IgG (CBAs are recommended), and (iii) the exclusion of alternative diagnoses such as MS, sarcoidosis, infections, neoplasms, and paraneoplastic disorders. This evidence concerns the gene AQP4 and neoplasm.